Skip to main content
. 2019 Apr 30;30(5):e86. doi: 10.3802/jgo.2019.30.e86

Fig. 3. PFS in patients who achieved clinical benefit at 3 months. The median duration of clinical benefit was 6.5 months (95% CI=2.8–11.7). Thirteen patients have progressed (5 censored).

Fig. 3

CI, confidence interval; CLB, clinical benefit; PFS, progression-free survival.